Business Context and Reporting Period
This summary covers the Form 10-Q for On Assignment, Inc. (Note: The input metadata lists "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.) for the quarterly period ended March 31, 2002. The company operates in two primary segments: Lab Support and Healthcare Staffing, providing temporary and permanent placement services for laboratory, scientific, and medical professionals.
Key Financial Metrics
| Metric | Q1 2002 | Q1 2001 |
|---|---|---|
| Revenues | $42,111,000 | $51,181,000 |
| Gross Profit | $13,545,000 | $16,727,000 |
| Operating Income | $4,210,000 | $6,808,000 |
| Net Income | $2,869,000 | $4,826,000 |
| Diluted EPS | $0.12 | $0.21 |
| Cash and Equivalents | $95,256,000 | $59,617,000 |
| Working Capital | $113,532,000 | N/A |
| Long-Term Debt | $0 | $0 |
Margins: Gross margin was approximately 32.2% in Q1 2002 compared to 32.7% in Q1 2001. Operating margin declined to 10.0% from 13.3%.
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 17.7% year-over-year. The Lab Support segment fell 19.9% due to a 19.7% drop in temporary employees on assignment and lower conversion fees. The Healthcare Staffing segment fell 12.1% due to fewer temporary employees, partially offset by a 39.2% increase in conversion fees.
- Cost Management: Cost of services decreased 17.1%, tracking closely with revenue declines. Selling, general, and administrative (SG&A) expenses decreased 5.9% due to planned cost reductions, though SG&A as a percentage of revenue increased from 19.4% to 22.2% due to the revenue drop.
- Cash Flow: Net cash provided by operating activities increased to $7.11 million from $6.46 million. Investing activities generated $19.34 million, primarily from the maturity of marketable securities ($22.4 million) offset by purchases ($2.0 million).
- Interest Income: Interest income dropped 45.0% to $444,000, attributed to lower interest rate yields despite higher cash balances.
Outlook, Risks, and Unusual Items
- Major Acquisition: On April 19, 2002 (post-period), the company acquired Health Personnel Options Corporation (HPO) for approximately $147 million. The purchase price included $66 million in cash, $9 million in assumed debt, and 3.9 million shares of common stock. A $5 million earn-out provision is held in escrow contingent on HPO meeting 2002 revenue targets.
- Liquidity: The company reported strong liquidity with $95.3 million in cash and no long-term debt. Management expects internally generated cash and borrowing ability to be sufficient for working capital needs, even post-acquisition.
- Accounting Changes: The company adopted SFAS No. 142 (Goodwill and Other Intangible Assets) on January 1, 2002, requiring impairment testing rather than amortization of goodwill. Management does not believe this will have a significant impact.
- Risks: Forward-looking statements highlight risks related to attracting/retaining staff, managing growth in international markets, and integrating acquired operations.
Investor Verification Checklist
- Verify the integration progress and financial performance of the newly acquired Health Personnel Options Corporation (HPO).
- Monitor the status of the $5 million earn-out provision related to the HPO acquisition.
- Assess the sustainability of revenue declines in the Lab Support segment and the effectiveness of cost reduction initiatives.
- Review the impact of lower interest rates on future investment income given the company's large cash position.
- Confirm the company's ability to maintain liquidity levels following the significant cash outlay for the HPO acquisition.